T memory stem cells isolation processing system for transfusion medicine

Added: Aug 12, 2016 3:55 pm The National Institutes of Health (NIH) intends to award a fixed priced purchase order on a sole source basis to Miltenyi Biotec, Inc., Auburn, CA, 95602 to procure the Miltenyi's MACSQuant® Tyto system. The Cell Processing Section (CPS) of the Department of Transfusion Medicine has a need for the isolation of antigen specific cells, especially for tumor-redicted T Memory stem cells (Tscm) which have demonstrated significant results in the treatment of malignancies. However, the available isolation system in CPS can only be used for the selection of bulk specific lineage cells and cannot select the rare Tscm populations. There is no other known instrumentation beyond the Miltenyi MACSQuant® Tyto with the ability to select and isolate the respective cells. Additionally, the appropriate accessories, ie, antibodies, buffers, tubings, bags, are required. A clinical trial is currently on hold due to the lack of a suitable cell isolation system. The MACSQuant® Tyto system is currently the only known cell sorter that can provide the appropriate cells necessary to fulfill the stated requirement.

This acquisition is being conducted using policies unique to the authority of the test program for commercial items prescribed in FAR Subpart 13.501 for sole source (including brand name) acquisitions. Interested concerns capable of providing the same or similar products or services as described in this notice may submit a capability statement outlining their capabilities. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. A determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

Each response should include the following Business Information:
a. DUNS.
b. Company Name, address, POC, Phone and Email address
c. Current GSA Schedules or NAICS codes appropriate to this Award.
d. Type of Company (i.e., small business, 8(a), woman owned, HUBZone, veteran owned, etc.) as validated in System For Award Management (SAM). All offerors must register on the SAM located at http://www.sam.gov/portal/SAM/#1
e. Capability Statement

Comments to this announcement may be submitted to the Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Malinda Dehner, Contract Specialist, dehnerm@cc.nih.gov by the due date and time marked in this notice.